United in Action to Accelerate Cures for Patients with AML
On Jan 31, 2025
Join The Leukemia & Lymphoma Society's (LLS) Therapy Acceleration Program® (TAP) for a live one-hour discussion panel via Zoom at 12 noon EST/9 am PST/ 6 pm CET
Hear Lawrence Mayer (former President & CSO at Celator Pharmaceuticals) speak about how TAP was a catalyst for the development of the FDA-approved Vyxeos!
The Leukemia & Lymphoma Society's thought leaders Ashley Yocum and Ann Cahill Collins will discuss our innovative Beat AML and PedAL initiatives!
Stephan Braun (CMO at ImCheck Therapeutics), TAP biotech partner, will be speaking about ICT01 and the encouraging clinical results from the recent ASH 2024 meeting!
Register here on TAP website
Back to events list